| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10916130 | Nuclear Medicine and Biology | 2012 | 8 Pages |
Abstract
FES PET imaging was able to reliably differentiate between tumors having differences in their ERα expression in vivo, in a mouse model. Quantitative data obtained by FES PET were in concordance with biodistribution studies and in vitro assays. It is concluded that FES PET imaging can likely be used to monitor subtle ER status changes during the course of hormone therapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
![[18F]-fluoroestradiol quantitative PET imaging to differentiate ER+ and ERα-knockdown breast tumors in mice](/preview/png/10916130.png "First Page Preview: [18F]-fluoroestradiol quantitative PET imaging to differentiate ER+ and ERα-knockdown breast tumors in mice")
Authors
Michel Paquette, René Ouellet, Mélanie Archambault, Ãtienne Croteau, Roger Lecomte, François Bénard,